Celltrion's coronavirus test kits hit U.S.
By Kim Han-joo
SEOUL, Aug. 12 (Yonahp) -- South Korean biopharmaceutical firm Celltrion Inc. said Wednesday that its two kinds of diagnostic kits for the novel coronavirus began sales in the United States.
A point-of-care antigen testing (POCT) kit, dubbed "Sampinute," co-developed by local health care firm BBB, was commercialized following emergency approval by the U.S. Food and Drug Administration, Celltrion said.
The POCT kit is a portable and highly sensitive device that reduces the test time to 10 minutes, according to Celltrion. The test time is considered the quickest among kits available on the market.
Celltrion said a rapid antibody diagnostic test (RDT) kit for the coronavirus, named "DiaTrust," also came out in the market. The test is co-developed by South Korean in-vitro diagnostic company Humasis.
The new antibody detection test is most suitable for identifying acute or early infection of the COVID-19 virus, Celltrion said.
khj@yna.co.kr
(END)
-
S. Korea to resume issuing short-term travel visas, e-visas next month
-
Ateez to drop new Japanese EP next week
-
(LEAD) At least 8 injured in S-Oil refinery explosion in Ulsan: firefighters
-
Hyundai Motor to invest US$5 bln in U.S. for robotics, autonomous driving development
-
(News Focus) S. Korean firms in delicate balancing act over U.S. economic framework
-
S. Korea to resume issuing short-term travel visas, e-visas next month
-
(5th LD) Yoon, Biden agree to expand joint military exercises to cope with N.K. threats
-
(LEAD) Yoon, PPP lawmakers travel to Gwangju en masse to commemorate 1980 democracy uprising
-
(LEAD) At least 8 injured in S-Oil refinery explosion in Ulsan: firefighters
-
(LEAD) Biden set to arrive in S. Korea for first summit with Yoon
-
Military develops new helmet capable of stopping stronger pistol rounds
-
Agencies remain silent as V of BTS, BLACKPINK's Jennie rumored to be dating
-
Biden says he and Yoon 'married up'
-
Premier League Golden Boot winner Son Heung-min receives hero's welcome home
-
U.S.-led IPEF outweighs China-involving RCEP in population, GDP